Online Program

295592
Health Equity & the Affordable Care Act: Charting Progress, Opportunities, and Challenges


Monday, November 4, 2013 : 12:50 p.m. - 1:10 p.m.

Nadia J. Siddiqui, MPH, Texas Health Institute, Austin, TX

Dennis P. Andrulis, PhD, MPH, Senior Research Scientist, Texas Health Institute, Austin, TX

Since the enactment of the Affordable Care Act, the Texas Health Institute has been monitoring the implementation progress of over 60 provisions intended to advance health equity across five priorities: health insurance exchanges; health care safety net; workforce support and diversity; research, data, and quality; and public health and prevention. These provisions either directly advance health equity by supporting or requiring actions specific to diversity, language access, or cultural competence, or broadly by potentially affecting large numbers of racially, ethnically, and linguistically diverse populations, such as Medicaid expansion. This presentation will highlight important opportunities in the law—both explicit and implicit—for advancing health equity across the five areas, while also discussing challenges and critical next steps for assuring equity remains a central priority for bridging longstanding disparities in the health care system.

Learning Areas:

Diversity and culture
Ethics, professional and legal requirements
Planning of health education strategies, interventions, and programs

Learning Objectives:
Identify specific opportunities and obligations for advancing health equity through the ACA. Discuss emerging models, best practices, and strategies for reaching and engaging racially and ethnically diverse communities through the ACA. Discuss challenges and important next steps for assuring equity remains a central priority to transforming the health care system.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have served as Senior Analyst/Project Director on a range of projects monitoring health care reform from a health equity perspective since shortly after President Obama’s inauguration in 2009 (nearly 5 years). I have presented on this topic at many scientific venues, such as APHA and NIH, and have co-authored nearly a dozen reports, including a peer-reviewed article in Health Affairs.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.